Mucopolysaccharidosis type II (Hunter disease): 13 gene mutations in 52 Japanese patients and carrier detection in four families
Tóm tắt
Southern blot analysis of the iduronate sulfatase (IDS) gene in 52 unrelated Japanese patients with mucopolysaccharidosis type II was carried out using a cDNA probe, and mutations in 13 patients (25%) were identified. Of these, 3 had partial gene deletions (in 2 the normal 9.4-kb fragment was absent and in 1 the normal 7.4-kb fragment was absent, as determined by Southern blot analysis using EcoRI-digested DNA, respectively), 2 had gene insertions (in 1 there was a unique 11.2kb fragment and in the other there was a unique 5kb fragment, determined by Southern blot analysis using EcoRI digested DNA), and 8 had rearrangements (in 6 the normal 9.4kb and 7.0kb fragments were absent and a unique 11.2kb fragment was present; in the remaining 2 patients there were different rearrangements). In these 13 patients, the similar Southern blot patterns were indicative of structural alterations of the IDS gene, as revealed when their DNA was digested with HindIII or PstI and probed with IDS cDNA. All patients with these structural alterations were in a clinically severe state, except for 1 with an intermediate clinical phenotype. Our analyses of four families among those of the 13 patients revealed that all four mothers were carriers. The detection of structural abnormalities led to a precise identification of Hunter heterozygotes and revealed one de novo rearrangement in a germ cell of one of the maternal grandparents.
Tài liệu tham khảo
Antonarakis SE, Waber PG, Kittur SD, Patel AS, Kazazian HH, Mellis MA, Counts RB, Stamatoyannopoulos G, Bowie EJW, Fass DN, Pittman DD, Wozney JM, Toole JJ (1985) Hemophilia A: detection of molecular defects and of carriers by DNA analysis. N Engl J Med 313:842–848
Bartlett RJ, Pericak-Vance MA, Koh J, Yamaoka LH, Chen JC, Hung WY, Speer MC, Wapenaar MC, Van Ommen GJ, Bakker E, Pearson PL, Kandt RS, Siddique T, Gilbert JR, Lee JE, Sirotkin-Roses MJ, Roses AD (1988) Duchenne muscular dystrophy: high frequency of deletions. Neurology 38:1–4
Bernstein HS, Bishop DF, Astrin KH, Kornreich R, Eng CM, Sakuraba H, Desnick RJ (1989) Fabry disease: six gene rearrangements and an exonic point mutation in the α-galactosidase gene. J Clin Invest 83:1390–1399
Bielicki J, Freeman C, Clements PR, Hopwood JJ (1990) Human liver iduronate-2-sulphatase: purification, characterization and catalytic properties. Biochem J 271:75–86
Darras BT, Blattner P, Harper JF, Spiro AJ, Alter S, Francke U (1988) Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: Location of breakpoints on HindIII and BglII exon containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet 43:620–629
Forrest SM, Cross GS, Speer A, Gardner-Medwin D, Burn J, Davis KE (1987) Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature 329:638–640
Haldane JBS (1935) The rate of spontaneous mutation of a human gene. J Genet 35:317–326
Hiraizumi Y (1989) A clinical and biochemical study of Hunter's syndrome. Acta Sch Med Univ Gifu 37:343–377
Jolly DJ (1986) The role of HPRT genes in human disease. In: Blasi F (eds) Human genes and diseases. Wiley, New York, pp 123–168
Kornreich R, Bishop DF, Desnick RJ (1990) α-Galactosidase A gene rearrangements causing Fabry disease. J Biol Chem 265:9319–9326
Mandel JL, Willard HF, Nussbaum RL, Romeo G, Puck JM, Davies KE (1989) Report of the committee on genetic constitution of the X chromosome. (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51:384–437
Mossman J, Blunt S, Stephens R, Jones EE, Pembrey M (1983) Hunter disease in a girl: association with X: 5 chromosomal translocation disrupting the Hunter gene. Arch Dis Child 58:911–915
Nakamura H (1987) Detection of Hunter heterozygotes. Acta Sch Med Univ Gifu 35:185–206
Palmieri G. Capra V, Romano G, D'Urso M, Johnson S, Schlessinger D, Morris P, Hopwood JJ, Natale PD, Gatti R, Ballabio A (1992) The iduronate sulfatase gene: isolation of a 1.2Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome. Genomics 12:52–57
Penrose LS (1955) Parental age and mutation. Lancet XIX:312–313
Roberts SH, Upadhyaya M, Safarazi M, Harper PS (1989) Further evidence localising the gene for Hunter's syndrome to the distal region of the X chromosome long arm. J Med Genet 26:309–313
Rozen R, Fox J, Fenton WA, Horwich AL, Rosenberg LE (1985) Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus. Nature 313:815–817
Sukegawa K, Tomatsu S, Tamai M, Ikeda M, Sasaki T, Masue M, Fukuda S, Yamada Y, Orii T (1992) Intermediate form of mucopolysaccharidosis type II (Hunter disease): A C1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun 183:809–813
Suthers GK, Callen DF, Hyland VJ, Kozman HM, Baker E, Eyre H, Harper PS, Roberts SH, Hors-Cayla MC, Davies KE, Bell MV, Sutherland GR (1989) A new DNA marker tightly linked to the fragile X locus (FRAXA). Science 246:1298–1300
Vogel F, Motulsky AG (1982) Human genetics problems and approaches. Springer, Berlin Heidelberg New York
Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Clements PR, Hopwood JJ (1990) Hunter syndrome: Isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 87:8531–8535
Wilson PJ, Suthers GK, Callen DF, Baker E, Nelson PV, Cooper A, Wraith JE, Sutherland GR, Morris CP, Hopwood JJ (1991) Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome. Hum Genet 86:505–508
Yang TP, Patel PI, Chinault AC, Stout JT, Jackson LG, Hildebrand BM, Caskey CT (1984) Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients. Nature 310:412–414
Youssoufian H, Antonarakis SE, Aronis S, Tsiftis G, Phillips DG, Kazazian HH (1987) Characterization of five partial deletions of the factor VIII gene. Proc Natl Acad Sci USA 84:3772–3776